1. Boussat S, El’rini T, Dubiez A, Depierre A, Barale F, Capellier G. Predictive factors of death in primary lung cancer patients on admission to the intensive care unit. Intensive Care Med. 2000;26(12):1811-1816. doi:10.1007/s001340000701
2. Yıldırım F, Akpınar S, Yurdakul AS. Lung cancer and intensive care: which patient how long? Tuberk Toraks. 2017;65(4):317-326. doi:10.5578/tt.57350
3. Xu H, Zheng X, Ai J, Yang L. Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: a systematic review and meta-analysis of 13,110 patients. Int Immunopharmacol. 2023;114:109496. doi:10.1016/j.intimp.2022.109496
4. Farag CM, Antar R, Akosman S, Ng M, Whalen MJ. What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types. Oncotarget. 2023;14:153-172. doi:10.18632/oncotarget.28367
5. Wu TH, Tsai YT, Chen KY, Yap WK, Luan CW. Utility of high-sensitivity modified Glasgow prognostic score in cancer prognosis: a systemic review and meta-analysis. Int J Mol Sci. 2023;24(2):1318. doi:10. 3390/ijms24021318
6. Cho A, Arfsten H, Goliasch G, et al. The inflammation-based modified Glasgow prognostic score is associated with survival in stable heart failure patients. ESC Heart Fail. 2020;7(2):654-662. doi:10.1002/ehf2.12625
7. Kocaoğlu S, Alatlı T. The efficiency of the HALP score and the modified HALP score in predicting mortality in patients with acute heart failure presenting to the emergency department. Am J Emerg Med. 2022;59:136-140.
8. Tian M, Li Y, Wang X, et al. The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is associated with poor outcome of acute ischemic stroke. Front Neurol. 2021;11:610318. doi:10.3389/fneur.2020.610318
9. Alshuweishi Y, Basudan AM, Alfaifi M, Daghistani H, Alfhili MA. Association of the HALP score with dyslipidemia: a large, nationwide retrospective study. Medicina (Kaunas). 2023;59(11):2002. doi:10.3390/medicina59112002
10. Guo Y, Zhai J, Chen H, et al. The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel significant prognostic factor for patients with metastatic prostate cancer undergoing cytoreductive radical prostatectomy. Cancer Manag Res. 2019;11:81-88.
11. Ekinci F, Balcik OY, Oktay E, Erdogan AP. HALP score as a New Prognostic Index in metastatic renal cell cancer. J Coll Physicians Surg Pak. 2022;32(3):313-318. doi:10.29271/jcpsp.2022.03.313
12. Nie D, Zhang L, Wang C, Guo Q, Mao X. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis. Arch Gynecol Obstet. 2020;301(6):1543-1551. doi:10.1007/s00404-020-05581-8
13. Walsh SM, Casey S, Kennedy R, Ravi N, Reynolds JV. Does the modified Glasgow prognostic score (mGPS) have a prognostic role in esophageal cancer? J Surg Oncol. 2016;113(7):732-737. doi:10.1002/jso.24225
14. Tunay B, Yılmaz S, Karadağ İ, et al. The modified Glasgow prognostic score (mGPS) and the mortality prediction model II (MPM II) can predict mortality in patients with breast cancer admitted to intensive care. Turk J Intensive Care. 2023;21(1):6-10. doi:10.28982/josam.7606
15. Kaplan C, Öztürk M, Doğanay M, et al. Evre III-IV over kanseri nedeniyle sitoredüktif cerrahi geçiren hastalarda postoperatif yoğun bakım gereksiniminin ön belirleyicileri. Turk J Gynecol Oncol. 2012;15(3):145-150. doi:10.4274/Tybdd.205
16. Özdemir U, Altıntaş N. Kanser hastalarının yoğun bakımda yönetimi. Yoğun Bakım Derg. 2024;15(1):35-42.